Hepatitis B virus infection and bone marrow transplantation (Q33757643)

29 July 2017

1 reference

title

Hepatitis B virus infection and bone marrow transplantation (English)

1 reference

29 July 2017

1 reference

1 reference

G K Lau

1

1 reference

29 July 2017

C K Lee

series ordinal

2

1 reference

29 July 2017

R Liang

series ordinal

3

1 reference

29 July 2017

publication date

1 June 1999

1 reference

Critical Reviews in Oncology Hematology

29 July 2017

published in

1 reference

29 July 2017

volume

31

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

71-76

1 reference

Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case controlled study

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Recovery from chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Clearance of hepatitis B surface antigen after bone marrow transplantation: Role of adoptive immunity transfer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Hepatitis B virus infection in allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Reactivated fulminant hepatitis B virus replication after bone marrow transplantation: clinical course and possible treatment with ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Fibrosing cholestatic hepatitis and HBV after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Fatal reactivation of precore mutant hepatitis B virus associated with fibrosing cholestatic hepatitis after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Hepatitis B infection in patients with lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Reactivation of chronic hepatitis B virus infection by cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Reactivation of chronic hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Cytokine inhibitors and graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Hepatitis B virus DNA contains a glucocorticoid-responsive element

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Hepatic venoocclusive disease in autologous bone marrow transplantation of solid tumors and lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

High-level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Increased hepatocyte expression of hepatitis B virus transcription in patients with features of fibrosing cholestatic hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Hepatitis B virus infection in Chinese families in Hong Kong.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Immunologic and molecular basis of viral persistence. The hepatitis B virus model

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Transplantation of hepatitis B immune lymphocytes as means for adoptive transfer of immunity to hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Immunization against hepatitis B through adoptive transfer of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Loss of HBsAg in chronic hepatitis B carrier following high-dose chemotherapy and autologous peripheral blood stem cell rescue for lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Autologous graft-versus-host disease: a novel approach for antitumor immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Pilot study of recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Long-term remission of chronic hepatitis B after alpha-interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Hepatitis B associated liver failure following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

Therapeutic vaccination of woodchucks against chronic woodchuck hepatitis virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900042-0

7 January 2021

10.1016/S1040-8428(98)00042-0

Identifiers

DOI

1 reference

29 July 2017

1 reference